Bristol-Myers Squibb Company (BMY)

NYSE - NYSE Real Time Price. Currency in USD
57.39+0.15 (+0.26%)
At close: 4:00 PM EDT
People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close57.24
Bid57.41 x 1900
Ask57.43 x 100
Day's Range56.92 - 57.51
52wk Range56.32 - 77.12
1y Target EstN/A
Market Cap95.89B
P/E Ratio (ttm)33.56
Avg Vol (3m)9,685,310
Dividend & Yield1.52 (2.59%)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Business Wire6 hours ago

    Bristol-Myers Squibb to Hold Investor Teleconference to Discuss ESMO 2016 Congress Highlights

    Bristol-Myers Squibb Company will host a teleconference on Sunday, October 9, 2016, at 7:30 p.m. CEST to discuss data presented at the European Society of Medical Oncology 2016 Congress in Copenhagen, Denmark.

  • Why Do Hedge Funds Like Five Prime Therapeutics?
    Insider Monkey13 hours ago

    Why Do Hedge Funds Like Five Prime Therapeutics?

    Five Prime Therapeutics Inc (NASDAQ:FPRX) is a $1.25 billion biotech company that focuses on the discovery and development of protein therapeutics that block cancer and inflammatory disease processes. In this article, we analyze hedge fund activity in the stock in the second quarter and take a closer look at the stock’s prospects. Hedge fund sentiment […]

  • StreetAuthority Networkyesterday

    This Pharma Company Is Leading The Race For A Zika Vaccine

    Sometimes, you'd think that the worst diseases to threaten mankind come from tropical environments. They do.  AIDS came from sub equatorial Africa, as did the Ebola virus.